Try our Advanced Search for more refined results
Securities
-
March 23, 2026
Cosmetics Giant Coty Faces Investor Suit Over Fragrance Biz
Beauty giant Coty Inc. faces a proposed investor class action alleging the company misled investors when it said it was poised for growth only to reverse course last month and say its earlier forecast was premature.
-
March 23, 2026
Polymarket Bars Insider Trading In Latest Rule Book Update
Polymarket announced Monday that it's updating its rule book to address insider trading in event contracts, explicitly barring trades on stolen confidential information, illegal tips or by those who can "influence the outcome" of a prediction market.
-
March 23, 2026
Oil Execs Face Fraud Claims Over Investment Tactics
Two oil and gas executives enticed investors to finance their venture by promising priority access to thousands of mineral acres, only to steer the deals through affiliated companies to profit themselves instead, a pair of investors have alleged.
-
March 23, 2026
Flagstar Seeks To Shut Down Ex-CCO's Retaliation Suit
Flagstar asked a New York federal judge to toss a suit from one of its former compliance chiefs that claims he was wrongfully terminated for blowing the whistle on the bank's former CEO over alleged compliance violations, saying the suit attempts to "cobble together" unrelated incidents into a retaliation claim.
-
March 23, 2026
FINRA Fines Stash Capital For AML, Identity Theft Controls
The Financial Industry Regulatory Authority fined digital investing platform operator Stash Capital $450,000 for allegedly failing to properly review applications and detect suspicious account activity during a period of sharp customer growth.
-
March 23, 2026
EV Co. Faraday Future Says SEC Probe Ended Without Action
The U.S. Securities and Exchange Commission is not recommending an enforcement action against electric vehicle startup Faraday Future Intelligent Electric Inc. after years of investigation, the company has told investors.
-
March 23, 2026
Revance Investors Ink $17M Deal In Take-Private Offer Suit
Dermal fillers company Revance Therapeutics Inc. and two of its executives have agreed to a $17 million settlement to end claims the company hurt investors after the value of a take-private tender offer was negotiated down following allegations that Revance had breached a distribution deal with another company.
-
March 23, 2026
J&J Amici Seek Clarity On Goldman Precedent For Class Cert.
Four groups of amici have urged the U.S. Supreme Court to take up Johnson & Johnson's challenge to a Third Circuit decision allowing a securities class action over its talc products to proceed, warning the ruling could reshape how shareholder suits are litigated nationwide.
-
March 23, 2026
Day Pitney Fights DQ Over Ex-Justice's Time On Case He Heard
Day Pitney LLP has apologized after former Connecticut Supreme Court Chief Justice Richard A. Robinson, now a firm partner, billed 15.7 hours for reviewing a since-remanded case he heard years ago as a justice, but the firm said the "error" should not disqualify its other lawyers from advancing the litigation.
-
March 23, 2026
Tenn. Regulators To Challenge Kalshi Win At 6th Circ.
Tennessee regulators are asking the Sixth Circuit to review an order barring them from taking action against Kalshi's sports contracts, marking the latest event contract dispute to reach an appeals court.
-
March 23, 2026
Bipartisan Bill Eyes Boosting Cannabis Business Investment
Members of Congress have reintroduced bipartisan legislation that would create a safe harbor for state-regulated marijuana businesses to access traditional business services without threat of federal enforcement and potentially be listed on securities exchanges.
-
March 23, 2026
SEC's Atkins Promises Changes To Adviser Pay-To-Play Rule
U.S. Securities and Exchange Commission Chairman Paul Atkins indicated Monday that his agency plans to loosen the rules around political contributions made by investment advisers, saying that current regulations present a "trap for the unwary."
-
March 23, 2026
Semiconductor Co. Can't End Suit Over Key Witness's Reversal
An investor's securities fraud suit accusing STMicroelectronics of failing to acknowledge pandemic-related declines in demand will proceed after a New York federal judge rejected the semiconductor manufacturer's bids for dismissal and reconsideration.
-
March 23, 2026
Federal Prosecutors Fight Bail Bid For Convicted Biotech CEO
Federal prosecutors are fighting former CytoDyn CEO Nader Pourhassan's bid to stay free on bail while he appeals his securities fraud and insider trading convictions, arguing in Maryland federal court that the executive's arguments on appeal are little more than recycled versions of the failed claims he made in seeking a new trial.
-
March 23, 2026
Senators Push Bill To Ban Sports Bets On Prediction Markets
A bipartisan pair of senators are looking to shutter sports contracts on prediction market platforms such as Kalshi and Polymarket, introducing a bill Monday to clarify that these types of offerings are under the jurisdiction of state gambling laws, not the Commodity Futures Trading Commission.
-
March 23, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court's docket this past week featured high-stakes disputes involving major consumer brands, a reinstated video game executive, revived noncompete and compensation claims and fresh allegations of corporate misconduct in the healthcare sector.
-
March 23, 2026
BJ's Says Pension Fund Oversteps With Climate Study Ask
BJ's Wholesale Club told a Massachusetts federal judge that it cannot be forced to poll shareholders on whether the retailer should study the effects of deforestation on its supply chains, calling it an improper attempt at "micromanagement."
-
March 20, 2026
CytoDyn Settles Investor Suit With $500K, 49M Shares
Biotechnology firm CytoDyn has agreed to dole out 49 million shares of common stock and pay $500,000 to end investors' proposed class action accusing the company of overstating the likelihood that the U.S. Food and Drug Administration would approve a drug it claimed could treat HIV and COVID-19.
-
March 20, 2026
SEC's $1B Broad Street Fraud Case Stays In Fla.
A private equity firm the U.S. Securities and Exchange Commission accused of defrauding investors in a $1 billion fund will have to face the lawsuit in Florida, after a federal judge there refused Friday to toss the case or move it to South Carolina, where the firm is based.
-
March 20, 2026
UBS Gets Final OCC Nod For US Arm To Be National Bank
The Office of the Comptroller of the Currency has granted final approval for UBS Group AG to convert its U.S. depository subsidiary into a national bank, a move the Swiss banking giant is touting as a boon for its stateside growth ambitions.
-
March 20, 2026
KBR Investors Revise Suit Over DOD Relocation Contract
A proposed class of investors has launched revised claims in a suit alleging engineering solutions company KBR Inc. misled the market about its joint venture's now terminated partnership with the government to assist in relocating military personnel.
-
March 20, 2026
BofA Hit With 2nd Class Suit Over Alleged $328M Crypto Scam
Bank of America and a New Jersey IRA‑LLC facilitator are facing a growing wave of litigation over their alleged roles in enabling the $328 million Goliath Ventures cryptocurrency scam, with two new federal class actions filed this week accusing them of helping steer retirement and investment funds into what prosecutors say was a massive Ponzi scheme.
-
March 20, 2026
Feds Don't Have To Reveal Probe Of BofA's Epstein Ties
The federal government does not have to disclose a possible investigation into Bank of America's alleged role in enabling Jeffrey Epstein's sex trafficking scheme, a New York federal judge said Friday, explaining his order earlier this month denying the bank's bid to stay a civil suit that has since been settled.
-
March 20, 2026
DOD Calls Anthropic's Supply Chain Risk Case Premature
The Pentagon urged the D.C. Circuit to reject Anthropic's attempt to halt the agency's designation of the artificial intelligence company as a supply chain risk to national security, arguing the designation is limited in scope, and that Anthropic's motion is premature.
-
March 20, 2026
Chubb Moves To Toss Shareholder's Climate Proposal Suit
Insurance company Chubb Ltd. is fighting an effort to place a climate-related question on its annual corporate ballot, telling a Washington, D.C., federal judge that the shareholder championing the proposal is attempting to micromanage its business.
Expert Analysis
-
What Productivity EO May Mean For Defense Industrial Base
President Donald Trump’s recent executive order barring stock buybacks and dividend payments by "underperforming" defense contractors represents a significant policy shift from traditional oversight of the defense industrial base toward direct intervention in corporate decision-making, say attorneys at Holland & Knight.
-
What's New In ISS' Benchmark Voting Policy Updates For 2026
Companies should audit their governance structures and disclosures to prepare for the upcoming proxy season in light of Institutional Shareholder Services' 2026 policy updates, which include tighter guardrails on capital structures and director compensation, and more disclosure-driven assessments of environmental and social shareholder proposals, say attorneys at Fenwick.
-
Navigating Privilege Law Patchwork In Dual-Purpose Comms
Three years after the U.S. Supreme Court declined to resolve a circuit split in In re: Grand Jury, federal courts remain split as to when attorney-client privilege applies to dual-purpose legal and business communications, and understanding the fragmented landscape is essential for managing risks, say attorneys at Covington.
-
Decoding The SEC's Plans To Revitalize The US IPO Market
Chairman Paul Atkins' recent speech showcased the U.S. Securities and Exchange Commission's plans to ease certain disclosure burdens, rein in politicized shareholder voting and mitigate litigation risk, which could encourage more U.S. companies to seek public listings stateside and make U.S. stock exchanges more competitive for foreign companies, say attorneys at Baker McKenzie.
-
Banking Regulation Themes To Anticipate In 2026
The banking enforcement and rulemaking agenda for this year is likely to reflect a mix of targeted reform, deregulatory recalibration and new priorities aligned with supervisory modernization, says Kim Prior at King & Spalding.
-
Easing Equity Research Firewall Shows SEC Open To Updates
The U.S. Securities and Exchange Commission’s recent agreement to modify a decades-old settlement meant to limit investment bankers’ influence over research analysts within major broker-dealer firms reflects a shift toward a commission that recognizes how rules can be modernized to lighten compliance burdens without eliminating core safeguards, say attorneys at Ropes & Gray.
-
Series
Calif. Banking Brief: All The Notable Legal Updates In Q4
The regulatory and litigation developments for California financial institutions in the fourth quarter of 2025 were incremental but consequential, with the Department of Financial Protection & Innovation relying on public enforcement actions to articulate expectations, and lawmakers and privacy regulators playing a role as well, says Stephen Britt at Stinson.
-
Series
Fly-Fishing Makes Me A Better Lawyer
Much like skilled attorneys, the best anglers prize preparation, presentation and patience while respecting their adversaries — both human and trout, says Rob Braverman at Braverman Greenspun.
-
4 Ways GCs Can Manage Growing Service Of Process Volume
As automation and arbitration increase the volume of legal filings, in-house counsel must build scalable service of process systems that strengthen corporate governance and manage risk in real time, says Paul Mathews at Corporation Service Co.
-
Series
NY Banking Brief: All The Notable Legal Updates In Q4
In the fourth quarter of last year, New York state enacted several developments that affect financial services regulation and business, cementing upcoming compliance obligations including cybersecurity best practices and retail stores' cash management, says Chris Bonner at Barclay Damon.
-
SDNY Atty Signals Return To Private Fund Valuation Scrutiny
Recent remarks by the U.S. Attorney for the Southern District of New York — hinting that regulators are renewing their focus on private fund advisers who overvalue portfolio assets to drive up investor fees — should prompt firms to review their valuation methodologies and address potential conflicts of interest now, say attorneys at Debevoise.
-
IP Appellate Decisions Show 4 Shifts In 2025
In 2025, intellectual property decisions issued by the Ninth, D.C., and Federal Circuits trended toward tightening doctrinal boundaries, whether to account for technological developments in existing legal regimes, or to refine areas with some ambiguity, says Nate Sabri at Perkins Coie.
-
Series
The Law Firm Merger Diaries: Forming Measurable Ties
Relationship-building should begin as early as possible in a law firm merger, as intentional pathways to bringing people together drive collaboration, positive client response, engagements and growth, says Amie Colby at Troutman.
-
Del. Dispatch: What Tesla Decision Means For Exec Comp
The recent Delaware Supreme Court decision granting Tesla CEO Elon Musk his full pay, now valued at $139 billion, following a yearslong battle appears to reject the view that supersized compensation may be inherently unfair to a corporation and its shareholders, say attorneys at Fried Frank.
-
Wis. Sanctions Order May Shake Up Securities Class Actions
A Wisconsin federal court’s recent decision to impose sanctions on a plaintiffs law firm for filing a frivolous Private Securities Litigation Reform Act complaint in Toft v. Harbor Diversified may cause both plaintiffs and defendants law firms to reconsider certain customary practices in securities class actions, says Jonathan Richman at Brown Rudnick.